The estimated Net Worth of James E Flaherty is at least $5.65 Million dollars as of 1 May 2014. James Flaherty owns over 18,189 units of Cardiovascular Systems stock worth over $2,283,540 and over the last 16 years James sold CSII stock worth over $3,364,019.
James has made over 24 trades of the Cardiovascular Systems stock since 2011, according to the Form 4 filled with the SEC. Most recently James sold 18,189 units of CSII stock worth $545,670 on 1 May 2014.
The largest trade James's ever made was selling 36,682 units of Cardiovascular Systems stock on 22 October 2013 worth over $984,912. On average, James trades about 8,457 units every 34 days since 2009. As of 1 May 2014 James still owns at least 114,177 units of Cardiovascular Systems stock.
You can see the complete history of James Flaherty stock trades at the bottom of the page.
James's mailing address filed with the SEC is 651 CAMPUS DRIVE, , ST. PAUL, MN, 55112.
Over the last 16 years, insiders at Cardiovascular Systems have traded over $72,999,461 worth of Cardiovascular Systems stock and bought 949,532 units worth $8,687,068 . The most active insiders traders include Capital Management Lp Camber, Augustine Lawlor, and Capital Ltdmaverick Capital.... On average, Cardiovascular Systems executives and independent directors trade stock every 14 days with the average trade being worth of $338,920. The most recent stock trade was executed by Martha Goldberg Aronson on 15 August 2022, trading 2,411 units of CSII stock currently worth $48,220.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company's orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.
Cardiovascular Systems executives and other stock owners filed with the SEC include: